L. Hjelte

Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
20252 citationsauthor #15
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden
20245 citationsauthor #3
MAIT cell counts are associated with the risk of hospitalization in COPD
20228 citationsauthor #3
Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination
20223 citationsauthor #14
The Effects of Aspergillus fumigatus Colonization on Lung Function in Patients with Cystic Fibrosis
20219 citationsauthor #5
WS19.5 Decrease of faecal calprotectin in adults after initiation of Orkambi®, a Registry-based study
20200 citationsauthor #6
P398 Most adult patients with cystic fibrosis at Stockholm Cystic Fibrosis Centre have a full-time or part-time occupation
20200 citationsauthor #4
P257 Assessing possible role of enterovirus infections in diabetes onset in a Swedish cohort of cystic fibrosis patients
20200 citationsauthor #4
A 16-year retrospective study on fungal prevalence and diversity in patients with Cystic Fibrosis- Candida dubliniensis was associated with a decline in lung function.
202017 citationsauthor #4
ADAPTATION OF STRATEGIES FOR CO-PRODUCTION OF CYSTIC FIBROSIS CARE DURING COVID-19: AN ANALYSIS USING THE THEORY OF DISTRIBUTED COGNITION
20200 citationsauthor #4
P073 The Cystic Fibrosis Atlas approach to community-based discovery and explanation of improvement needs and inequalities of care
20200 citationsauthor #7
S13.2 The Swedish cystic fibrosis Registry facilitates the evaluation of Orkambi® treatment
20200 citationsauthor #4
P068 Presence of Candida dubliniensis in the cystic fibrosis respiratory tract was associated with a significant decline in lung function – results from a 16-year retrospective study
20180 citationsauthor #5
P252 When doctors go to patients: a patient-based evaluation of the CFQ
20180 citationsauthor #5
Severely Impaired Control of Bacterial Infections in a Patient With Cystic Fibrosis Defective in Mucosal-Associated Invariant T Cells.
201831 citationsauthor #5
393 Anxiety and depression can predict the development in lung function in adults with cystic fibrosis
20171 citationsauthor #2
A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense
201710 citationsauthor #13
Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial
201742 citationsauthor #6
Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial
201742 citationsauthor #5
Non‐invasive Ventilation as Airway Clearance Technique in Cystic Fibrosis
201732 citationsauthor #3
84 Unexpectedly severe infection susceptibility in a CF patient defective in MAIT cells
20170 citationsauthor #5
264 Natural history of patients with cystic fibrosis carrying nonsense mutations: an analysis of placebo-treated patients from the 009 study
20164 citationsauthor #3
Associations between genetics, medical status, physical exercise and psychological well-being in adults with cystic fibrosis
201610 citationsauthor #3
Psychometric evaluation of the Swedish translation of the revised Cystic Fibrosis Questionnaire in adults
20166 citationsauthor #3
Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function
20161 citationsauthor #6
WS13.1 Ataluren significantly reduces exacerbations in nonsense mutation cystic fibrosis patients not receiving tobramycin
20164 citationsauthor #5
Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D
20168 citationsauthor #5
WS13.1.1 Ataluren in nonsense mutation cystic fibrosis patients not receiving tobramycin: significant lung function benefits in the paediatric age range
20164 citationsauthor #6
WS02.2 Gastrostomy tubes in patients with cystic fibrosis in Sweden
20160 citationsauthor #5
Depression and Anxiety among Parents of Children with Cystic Fibrosis Related to the Children’s Health Related Quality of Life
201511 citationsauthor #4
Anxiety and depression in adults with cystic fibrosis: a comparison between patients and the general population in Sweden and three other European countries
201515 citationsauthor #4
WS15.4 Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D
20140 citationsauthor #3
113 Increased susceptibility to enterovirus infections in a model for cystic fibrosis is associated with an impaired innate and adaptive antiviral immune response
20140 citationsauthor #8
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
201437 citationsauthor #6
Time Point to Perform Lung Function Tests Evaluating the Effects of an Airway Clearance Therapy Session in Cystic Fibrosis
201410 citationsauthor #2
cystic fibrosis patients. Increased oral bioavailability of ciprofloxacin in
20130 citationsauthor #1
252 Survey of malignancies at Scandinavian CF centers
20130 citationsauthor #11
WS16.3 Vitamin D supplementation in patients with cystic fibrosis: A pilot randomized controlled trial
20130 citationsauthor #3
317 Depression, anxiety and quality of life in adolescents with cystic fibrosis
20130 citationsauthor #3
WS9.4 Non invasive ventilation as airway clearance technique compared to PEP in adult patients with cystic fibrosis
20136 citationsauthor #2
187 The need for bronchodilators before airway clearance therapy sessions in CF
20120 citationsauthor #2
232 Gastrointestinal cancer survey at the Stockholm CF Center
20120 citationsauthor #2
Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study
201143 citationsauthor #10
241 When should lung function test be performed to evaluate the effects of an airway clearance therapy session in children and adults with cystic fibrosis
20110 citationsauthor #2
Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening.
20117 citationsauthor #4
Parental support for newborn screening for cystic fibrosis
20119 citationsauthor #4
The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from cystic fibrosis airway epithelial cells.
20119 citationsauthor #3
Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations
201119 citationsauthor #12
Mental health and sense of coherence among Swedish adults with cystic fibrosis.
201118 citationsauthor #2
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
2011149 citationsauthor #5
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study
201164 citationsauthor #11
Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
201133 citationsauthor #2
274* Recurrent pancreatitis among cystic fibrosis (CF) patients at Stockholm CF Centre. Correlations with genotype
20110 citationsauthor #3
Gender differences in the Scandinavian cystic fibrosis population
201051 citationsauthor #3
Vitamin D status in Stockholm cystic fibrosis patients in 2007–2009
20103 citationsauthor #2
Evaluation of European protocols for measuring nasal potential differences
20093 citationsauthor #8
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
200969 citationsauthor #6
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
200977 citationsauthor #10
Sequence and MLPA analyses found CFTR mutations in all patients with classic CF
20090 citationsauthor #4
Mutations in the amiloride‐sensitive epithelial sodium channel in patients with cystic fibrosis‐like disease
200990 citationsauthor #14
Expression of Intestinal and Lung Alkaline Sphingomyelinase and Neutral Ceramidase in Cystic Fibrosis F508del Transgenic Mice
20089 citationsauthor #2
Immunomodulatory properties of vitamin D in Scandinavian cystic fibrosis patients
20080 citationsauthor #4
ENaC mutations in patients with CF-like disease
20080 citationsauthor #16
Chitosan as a carrier for non‐viral gene transfer in a cystic‐fibrosis cell line
200818 citationsauthor #3
Effect of moisture tent on the ion content of nasal fluid in patients with cystic fibrosis
20080 citationsauthor #3
Disadvantage for patients over 24 months at diagnosis of cystic fibrosis
20080 citationsauthor #4
When is a lung function test to be performed evaluating the effects of an airway clearance therapy session in CF
20080 citationsauthor #2
223 Inverse gender gap in nutritional status; Scandinavian CF study consortium
20070 citationsauthor #7
234 Status of fat soluble vitamins in Scandinavian CF patients
20070 citationsauthor #6
105 Genomic fingerprinting of Pseudomonas aeruginosa isolates from all Swedish CF Centres. A Scandinavian Cystic Fibrosis Study Consortium study
20072 citationsauthor #7
Tracheal structure abnormalities in Cftr − / − knockout mice
20070 citationsauthor #25
193 Major differences in pancreatic enzyme replacement in Scandinavia
20070 citationsauthor #1
Response to Commentary on the effects of a ketogenic diet enriched with omega-3 polyunsaturated fatty acids on plasma phospholipid fatty acid profile in children with drug-resistant epilepsy
20074 citationsauthor #2
156* Lung function in children with CF – from infants to seven years old
20070 citationsauthor #2
Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy.
200774 citationsauthor #2
126 Sphingomyelinase and ceramidase activities in tissues of delta-F508 CFTR mice
20070 citationsauthor #3
79 Bacterial contamination of PEP masks
20070 citationsauthor #4
37 Effect of mist tent on ion content of nasal fluid in patients with cystic fibrosis
20070 citationsauthor #3
114 Pseudomonas aeruginosa transmission at a winter camp in spite of rigorous precautions
20073 citationsauthor #5
Long-term clearance from small airways in subjects with ciliary dysfunction
200612 citationsauthor #3
299 Nutritional intake in CF patients in Norway and Sweden
20060 citationsauthor #6
38 PUFA-mediated CI− transport regulation in model airway cells
20060 citationsauthor #6
Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione
200637 citationsauthor #5
460 Gender differences in the Scandinavian CF population
20061 citationsauthor #3
392 Mental health and sense of coherence in Swedish Cystic Fibrosis adults. A pilot study
20060 citationsauthor #2
306 Growth parameters in Scandinavian CF patients
20061 citationsauthor #1
Long-term clearance from small airways in patients with cystic fibrosis
200527 citationsauthor #4
Arachidonic Acid and Ischemic Heart Disease 1
20050 citationsauthor #1
Arachidonic acid and ischemic heart disease.
200536 citationsauthor #1
Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro.
20044 citationsauthor #2
Heparin improves the viability of transfected cyctic fibrosis cell lines.
20040 citationsauthor #2
Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells.
200454 citationsauthor #3
Early chemotherapy for non‐tuberculous mycobacterial infections in patients with cystic fibrosis
200328 citationsauthor #3
Predictors of deterioration of lung function in cystic fibrosis *
2002191 citationsauthor #3
Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
200216 citationsauthor #3
[Forced expiration is a good way to measure lung function in infants and small children. Experiences from the Huddinge University Hospital and Karnsjukhuset in Skovde].
20020 citationsauthor #7
Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis.
200284 citationsauthor #6
Assessment of chloride secretion in human nasal epithelial cells by X‐ray microanalysis
200112 citationsauthor #4
Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity Note
20013 citationsauthor #6
Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
200029 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT